BANK OF AMERICA CORP /DE/
BankPosition in NMRA — Neumora Therapeutics, Inc.
CIK 70858
CHARLOTTE, NC
Position in NMRA
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$170,686
-$174,321 QoQ
Shares Held
100,404
-43.3% QoQ
Ownership
0.053%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#54
of 111 holders
Holding Since
Dec 2023
11 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NMRA Over Time
Shares Held
Position Value (USD)
Derivatives in NMRA
reported options exposure · as of Dec 31, 2024CallValue
$0
CallShares
0
PutValue
$106,000
PutShares
10,000
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026BANK OF AMERICA CORP /DE/ holds $10,050,306,032 across 338 Biotechnology names. NMRA ranks #288 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,039,178 | $1,509,650,884 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,291,053 | $805,023,185 | |
| 3 | CYTK |
Cytokinetics Inc
|
4,635,709 | $394,916,048 | |
| 4 | ARGX |
Argenx SE
|
400,234 | $371,325,094 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
994,476 | $299,367,107 | |
| 6 | JAZZ |
Jazz Pharmaceuticals plc
|
1,136,091 | $273,763,844 | |
| 7 | TVTX |
Travere Therapeutics, Inc.
|
4,568,341 | $259,527,450 | |
| 8 | RPRX |
Royalty Pharma plc
|
4,149,422 | $232,658,090 |
All Filings in NMRA
Export CSV
12 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $170,686 | 100,404 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $345,007 | 176,927 | Shares | Defined | 2026-05-18 | |
| 2025-12-31 | $183,311 | 102,409 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $250,119 | 137,429 | Shares | Defined | 2026-02-03 | |
| 2025-06-30 | $52,320 | 71,380 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $869,022 | 869,022 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $1,009,776 | 95,262 | Shares | Defined | 2025-02-14 | |
| 2024-12-31 | $106,000 | 10,000 | Put | Defined | 2025-02-14 | |
| 2024-09-30 | $883,722 | 66,898 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $590,880 | 60,110 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $303,722 | 22,089 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $257,794 | 15,120 | Shares | Defined | 2024-02-14 | |
| No filing history on record for this holder in this stock. | ||||||